Skip to main content

Greedy Insider

CLOV Insider Trades and Greediness Scores

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) insider trades: since Dec 14, 2025, Greedy Insider recorded 0 open-market buys and 72 sales on Form 4 from 10 insiders. The strongest recent filing scored 93 (Strong).

Who bought and who sold

Across the last 72 scoreable Form 4 transactions in CLOV, 0 were open-market purchases and 72 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.

InsiderRoleTypeSharesDateScore
Soares KarenChief Legal OfficerSell19275.089821.52026-10-2087View
Reynoso Jamie L.CEO, Medicare AdvantageSell4066.017931.062026-10-1980View
Toy AndrewCEOSell62176.0290983.72026-10-1576View
Soares KarenChief Legal OfficerSell14673.068669.642026-10-1582View
Wai ConradCEO, Counterpart HealthSell23627.0110574.362026-10-1571View
THORNTON JOSEPH CLAYInterim CFOSell4591.021485.882026-10-1576View
Reynoso Jamie L.CEO, Medicare AdvantageSell18273.085517.642026-10-1589View
Reynoso Jamie L.CEO, Medicare AdvantageSell2006.09287.782026-10-0766View
Reynoso Jamie L.CEO, Medicare AdvantageSell8750.038675.02026-10-0576View
Toy AndrewCEOSell318806.01335797.12026-10-0179View

The strongest recent filing

Soares Karen (Chief Legal Officer) sold 51,700 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE on Jul 20, 2026, a filing that scored 93 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.

Cluster activity

A cluster buy is present: 5 insiders (Soares Karen, Reynoso Jamie L., Wai Conrad, Toy Andrew) traded CLOV the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.

How this compares with CLOVER HEALTH INVESTMENTS, CORP. /DE's own history

Open-market buys make up 0% of the 72 scoreable CLOV transactions on record between Dec 14, 2025 and Oct 20, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.

Methodology and sources

Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.

Key facts

  • Scoreable Form 4 transactions on record: 72
  • Open-market buys: 0
  • Sales: 72
  • Distinct insiders: 10
  • Strongest recent Greediness Score: 93 (Strong)

Primary sources

Related

The score describes the filing, not future returns. This is not investment advice.